Akari Therapeutics, Plc ( AKTX) - Stock Earnings
AKTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -5.3 million USD | — USD |
| 2026Q1 | -14.5 million USD | — USD |
| 2026Q2 | -4.8 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
AKTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.0 million USD | — USD |
| 2024 | -19.8 million USD | — USD |
| 2025 | -17.3 million USD | — USD |
| 2026 Est. | — | — |
AKTX
Price: $8.62
52 week price:
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 16739
Ebitda: -8.5 millionMarket Capitalization: 19.8 million